205 related articles for article (PubMed ID: 21760855)
1. Progesterone receptor-B induction of BIRC3 protects endometrial cancer cells from AP1-59-mediated apoptosis.
Neubauer NL; Ward EC; Patel P; Lu Z; Lee I; Blok LJ; Hanifi-Moghaddam P; Schink J; Kim JJ
Horm Cancer; 2011 Jun; 2(3):170-81. PubMed ID: 21760855
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of AKT with the orally active allosteric AKT inhibitor, MK-2206, sensitizes endometrial cancer cells to progestin.
Pant A; Lee II; Lu Z; Rueda BR; Schink J; Kim JJ
PLoS One; 2012; 7(7):e41593. PubMed ID: 22911820
[TBL] [Abstract][Full Text] [Related]
3. Akt regulates progesterone receptor B-dependent transcription and angiogenesis in endometrial cancer cells.
Lee II; Maniar K; Lydon JP; Kim JJ
Oncogene; 2016 Sep; 35(39):5191-201. PubMed ID: 26996671
[TBL] [Abstract][Full Text] [Related]
4. The regulation and function of the forkhead transcription factor, Forkhead box O1, is dependent on the progesterone receptor in endometrial carcinoma.
Ward EC; Hoekstra AV; Blok LJ; Hanifi-Moghaddam P; Lurain JR; Singh DK; Buttin BM; Schink JC; Kim JJ
Endocrinology; 2008 Apr; 149(4):1942-50. PubMed ID: 18096667
[TBL] [Abstract][Full Text] [Related]
5. Chemosensitization of endometrial cancer cells through AKT inhibition involves FOXO1.
Hoekstra AV; Ward EC; Hardt JL; Lurain JR; Singh DK; Buttin BM; Schink JC; Kim JJ
Gynecol Oncol; 2008 Mar; 108(3):609-18. PubMed ID: 18234299
[TBL] [Abstract][Full Text] [Related]
6. [Functional study of progesterone receptor isoforms in endometrial cancer cell lines].
Lu Y; Liao QP; Chen CL; Yu L
Beijing Da Xue Xue Bao Yi Xue Ban; 2006 Oct; 38(5):475-9. PubMed ID: 17068617
[TBL] [Abstract][Full Text] [Related]
7. Critical tumor suppressor function mediated by epithelial Mig-6 in endometrial cancer.
Kim TH; Lee DK; Cho SN; Orvis GD; Behringer RR; Lydon JP; Ku BJ; McCampbell AS; Broaddus RR; Jeong JW
Cancer Res; 2013 Aug; 73(16):5090-9. PubMed ID: 23811943
[TBL] [Abstract][Full Text] [Related]
8. Selective down-regulation of progesterone receptor isoform B in poorly differentiated human endometrial cancer cells: implications for unopposed estrogen action.
Kumar NS; Richer J; Owen G; Litman E; Horwitz KB; Leslie KK
Cancer Res; 1998 May; 58(9):1860-5. PubMed ID: 9581825
[TBL] [Abstract][Full Text] [Related]
9. CRISPR/Cas9-Mediated Gene Knockout of ARID1A Promotes Primary Progesterone Resistance by Downregulating Progesterone Receptor B in Endometrial Cancer Cells.
Wang H; Tang Z; Li T; Liu M; Li Y; Xing B
Oncol Res; 2019 Sep; 27(9):1051-1060. PubMed ID: 31072420
[TBL] [Abstract][Full Text] [Related]
10. ck2-dependent phosphorylation of progesterone receptors (PR) on Ser81 regulates PR-B isoform-specific target gene expression in breast cancer cells.
Hagan CR; Regan TM; Dressing GE; Lange CA
Mol Cell Biol; 2011 Jun; 31(12):2439-52. PubMed ID: 21518957
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of AKT survival pathway by a small molecule inhibitor in human endometrial cancer cells.
Jin X; Gossett DR; Wang S; Yang D; Cao Y; Chen J; Guo R; Reynolds RK; Lin J
Br J Cancer; 2004 Nov; 91(10):1808-12. PubMed ID: 15505622
[TBL] [Abstract][Full Text] [Related]
12. Increased AKT or MEK1/2 activity influences progesterone receptor levels and localization in endometriosis.
Eaton JL; Unno K; Caraveo M; Lu Z; Kim JJ
J Clin Endocrinol Metab; 2013 Dec; 98(12):E1871-9. PubMed ID: 24064688
[TBL] [Abstract][Full Text] [Related]
13. Knockdown of long non-coding HOTAIR enhances the sensitivity to progesterone in endometrial cancer by epigenetic regulation of progesterone receptor isoform B.
Chi S; Liu Y; Zhou X; Feng D; Xiao X; Li W; Zhao Y; Wang H
Cancer Chemother Pharmacol; 2019 Feb; 83(2):277-287. PubMed ID: 30443761
[TBL] [Abstract][Full Text] [Related]
14. Progesterone-induced inhibition of growth and differential regulation of gene expression in PRA- and/or PRB-expressing endometrial cancer cell lines.
Smid-Koopman E; Kuhne LC; Hanekamp EE; Gielen SC; De Ruiter PE; Grootegoed JA; Helmerhorst TJ; Burger CW; Brinkmann AO; Huikeshoven FJ; Blok LJ
J Soc Gynecol Investig; 2005 May; 12(4):285-92. PubMed ID: 15866122
[TBL] [Abstract][Full Text] [Related]
15. Estrogen promotes breast cancer cell survival in an inhibitor of apoptosis (IAP)-dependent manner.
Stanculescu A; Bembinster LA; Borgen K; Bergamaschi A; Wiley E; Frasor J
Horm Cancer; 2010 Jun; 1(3):127-35. PubMed ID: 21152357
[TBL] [Abstract][Full Text] [Related]
16. Progestins activate the AKT pathway in leiomyoma cells and promote survival.
Hoekstra AV; Sefton EC; Berry E; Lu Z; Hardt J; Marsh E; Yin P; Clardy J; Chakravarti D; Bulun S; Kim JJ
J Clin Endocrinol Metab; 2009 May; 94(5):1768-74. PubMed ID: 19240153
[TBL] [Abstract][Full Text] [Related]
17. Membrane progesterone receptors (mPRs) mediate progestin induced antimorbidity in breast cancer cells and are expressed in human breast tumors.
Dressing GE; Alyea R; Pang Y; Thomas P
Horm Cancer; 2012 Jun; 3(3):101-12. PubMed ID: 22350867
[TBL] [Abstract][Full Text] [Related]
18. Distinct functional differences of human progesterone receptors A and B on gene expression and growth regulation in two endometrial carcinoma cell lines.
Smid-Koopman E; Blok LJ; Kühne LC; Burger CW; Helmerhorst TJ; Brinkmann AO; Huikeshoven FJ
J Soc Gynecol Investig; 2003 Jan; 10(1):49-57. PubMed ID: 12517594
[TBL] [Abstract][Full Text] [Related]
19. Identification of a novel mechanism of NF-kappaB inactivation by progesterone through progesterone receptors in Hec50co poorly differentiated endometrial cancer cells: induction of A20 and ABIN-2.
Davies S; Dai D; Feldman I; Pickett G; Leslie KK
Gynecol Oncol; 2004 Aug; 94(2):463-70. PubMed ID: 15297189
[TBL] [Abstract][Full Text] [Related]
20. miR-205 inhibits cell growth by targeting AKT-mTOR signaling in progesterone-resistant endometrial cancer Ishikawa cells.
Zhuo Z; Yu H
Oncotarget; 2017 Apr; 8(17):28042-28051. PubMed ID: 28427207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
